TY - JOUR
T1 - Patients with chronic gastrointestinal ischemia have a higher cardiovascular disease risk and mortality
AU - Sana, Aria
AU - van Noord, Désirée
AU - Mensink, Peter B.F.
AU - Kooij, Stephanie
AU - van Dijk, Kim
AU - Bravenboer, Bert
AU - Lieverse, Aloysius G.
AU - Sijbrands, Eric J.G.
AU - Langendonk, Janneke G.
AU - Kuipers, Ernst J.
PY - 2012/9
Y1 - 2012/9
N2 - Objectives: We determined the prevalence of classical risk factors for atherosclerosis and mortality risk in patients with CGI. Methods: A case-control study was conducted. Patients referred with suspected CGI underwent a standard work-up including risk factors for atherosclerosis, radiological imaging of abdominal vessels and tonometry. Cases were patients with confirmed atherosclerotic CGI. Controls were healthy subjects previously not known with CGI. The mortality risk was calculated as standardized mortality ratio derived from observed mortality, and was estimated with ten-year risk of death using SCORE and PREDICT. Results: Between 2006 and 2009, 195 patients were evaluated for suspected CGI. After a median follow-up of 19 months, atherosclerotic CGI was diagnosed in 68 patients. Controls consisted of 132 subjects. Female gender, diabetes, hypercholesterolemia, a personal and family history of cardiovascular disease (CVD), and current smoking are highly associated with CGI. After adjustment, female gender (OR 2.14 95% CI 1.05-4.36), diabetes (OR 5.59, 95% CI 1.95-16.01), current smoking (OR 5.78, 95% CI 2.27-14.72), and history of CVD (OR 21.61, 95% CI 8.40-55.55) remained significant. CGI patients >55 years had a higher median ten-year risk of death (15% vs. 5%, P = 0.001) compared to controls. During follow-up of 116 person-years, standardized mortality rate was higher in CGI patients (3.55; 95% CI 1.70-6.52). Conclusions: Patients with atherosclerotic CGI have an increased estimated CVD risk, and severe excess mortality. Secondary cardiovascular prevention therapy should be advocated in patients with CGI.
AB - Objectives: We determined the prevalence of classical risk factors for atherosclerosis and mortality risk in patients with CGI. Methods: A case-control study was conducted. Patients referred with suspected CGI underwent a standard work-up including risk factors for atherosclerosis, radiological imaging of abdominal vessels and tonometry. Cases were patients with confirmed atherosclerotic CGI. Controls were healthy subjects previously not known with CGI. The mortality risk was calculated as standardized mortality ratio derived from observed mortality, and was estimated with ten-year risk of death using SCORE and PREDICT. Results: Between 2006 and 2009, 195 patients were evaluated for suspected CGI. After a median follow-up of 19 months, atherosclerotic CGI was diagnosed in 68 patients. Controls consisted of 132 subjects. Female gender, diabetes, hypercholesterolemia, a personal and family history of cardiovascular disease (CVD), and current smoking are highly associated with CGI. After adjustment, female gender (OR 2.14 95% CI 1.05-4.36), diabetes (OR 5.59, 95% CI 1.95-16.01), current smoking (OR 5.78, 95% CI 2.27-14.72), and history of CVD (OR 21.61, 95% CI 8.40-55.55) remained significant. CGI patients >55 years had a higher median ten-year risk of death (15% vs. 5%, P = 0.001) compared to controls. During follow-up of 116 person-years, standardized mortality rate was higher in CGI patients (3.55; 95% CI 1.70-6.52). Conclusions: Patients with atherosclerotic CGI have an increased estimated CVD risk, and severe excess mortality. Secondary cardiovascular prevention therapy should be advocated in patients with CGI.
KW - Atherosclerosis
KW - BMI
KW - CACS
KW - Cardiovascular disease
KW - CGI
KW - Chronic gastrointestinal ischemia
KW - CTA
KW - IQR
KW - Mortality
KW - MRA
KW - NOMI
KW - SMR
UR - http://www.scopus.com/inward/record.url?scp=84865385104&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84865385104&partnerID=8YFLogxK
U2 - 10.1016/j.atherosclerosis.2012.07.007
DO - 10.1016/j.atherosclerosis.2012.07.007
M3 - Article
C2 - 22862964
AN - SCOPUS:84865385104
SN - 0021-9150
VL - 224
SP - 235
EP - 241
JO - Atherosclerosis
JF - Atherosclerosis
IS - 1
ER -